Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
Holding NTLA?
Track your performance easily
Blogger Sentiment
Sector Average
Bullish
Blogger Article Distribution
63% InvestorPlace
26% MotleyFool
5% Investing
6% Others
The distribution of articles among the main online Financial Blogging platforms.
Top Blogger Bearish Predictions
Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.
Top Blogger Bullish Predictions
3 High-Risk Undervalued Stocks for Aggressive Investors Targeting 35%+ Upside
3 Biotech Stocks With Promising Drug Pipelines: August 2024
The 3 Best Cathie Wood Stocks to Buy in August 2024
Recent positive articles by top bloggers.
Financial Blogger Predictions
Blogger Performance
Any
Blogger Sentiment
Any
The Motley Fool
Bullish
3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition
The Motley Fool
Bullish
The Bull Case for Intellia Therapeutics Stock Just Got Even Stronger
TipRanks Contributor
Bullish
The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024
TipRanks Contributor
Bullish
Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet
FAQ
What do Seeking Alpha bloggers think of NTLA?
Seeking Alpha’s Ian Cooper has a Bullish Sentiment.
What do Motley Fool contributors think of NTLA?
Currently there's no blogger sentiment for NTLA.
What Is NTLA’s Blogger Sentiment?
NTLA’s Blogger Sentiment is Bullish.
What was the most recent blogger prediction for NTLA?
The most recent blogger prediction for NTLA was made by Investing.com , who was Bullish on the stock.
How can I follow the stock ratings of top Top Financial Bloggers?
Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.